Podcast appearances and mentions of George Goldsmith

On the latest episode of the podcast, Jamie reminds listeners that the name of our podcast is not Good Times Great Sound Quality, Doug get distracted talking about the plot of an old episode of The Cosby Show, and we both break into a laughing fit looking at a still from this movie on our phones. Stay out of the haunted basement of hospitals, also stay out of their experimental laser research wing, and join us as we discuss a movie that changed its title in marketing but never on screen with that very oddly titled, Blue Monkey!Blue Monkey is a 1987 film directed by William Fruet, written by George Goldsmith and starring Steve Railsback, Gwynyth Walsh, Don Lake, Helen Hughes, Ivan E. Roth, Susan Anspach, Joe Flaherty, Robin Duke, Sarah Polley & John VernonVisit our YouTube ChannelMerch on TeePublic Follow us on TwitterFollow on InstagramFind us on FacebookVisit our WebsiteDoug's Schitt's Creek podcast, Schitt's & Giggles can be found here: https://podcasts.apple.com/us/podcast/schitts-and-giggles-a-schitts-creek-podcast/id1490637008

What better way to bring in Thanksgiving, a holiday full of eating food, laughing with relatives, and watching football, than with beginning our series that's going to close our look at Stephen King's Night Shift Collection. That's the good news. The bad news, is Children of the Corn is a series that contains 11 movies! Here, we start from the beginning, 1984's original Linda Hamilton starring original film. King himself wrote a treatment that got discarded because one, he didn't have nearly as much clout at this time. But as a result of King being booted from the creative process of making the movie, the oncoming regime of director Fritz Kiersch and screenwriter George Goldsmith had to work with a budget that was sliced by half a million dollars, which was given to the disgruntled author in order to retain his name in the credits. And this is just the beginning. Listen in as Garrett, Matt, and Adam start what is both literally and figuratively amongst the longest retrospectives they have ever done. Can they last this part of the King retrospective without killing each other with scythes? Download the show to find out!!

What better way to bring in Thanksgiving, a holiday full of eating food, laughing with relatives, and watching football, than with beginning our series that's going to close our look at Stephen King's Night Shift Collection. That's the good news. The bad news, is Children of the Corn is a series that contains 11 movies! Here, we start from the beginning, 1984's original Linda Hamilton starring original film. King himself wrote a treatment that got discarded because one, he didn't have nearly as much clout at this time. But as a result of King being booted from the creative process of making the movie, the oncoming regime of director Fritz Kiersch and screenwriter George Goldsmith had to work with a budget that was sliced by half a million dollars, which was given to the disgruntled author in order to retain his name in the credits. And this is just the beginning. Listen in as Garrett, Matt, and Adam start what is both literally and figuratively amongst the longest retrospectives they have ever done. Can they last this part of the King retrospective without killing each other with scythes? Download the show to find out!!

In a recent insightful interview, George Goldsmith, the visionary entrepreneur and founder of Compass Pathways, shared the rich tapestry of his life and career. He has had a journey that unfolded in unexpected ways, defying conventional norms.

Psilocybin–the active ingredient naturally found in psychedelic magic mushrooms–is increasingly being used to help fight what is often called ‘treatment-resistant depression' among other mental illnesses. COMPASS Pathways is one bold healthcare venture on a mission to fight human suffering at scale using a combination of a one-time psilocybin treatment, ongoing therapy and digital tools. To discuss this new direction for mental healthcare, we are joined by COMPASS Pathways Co-Founder and Chairman, George Goldsmith, as well as Ed Bolton, Creative Director of Brand in frog London. George and his team at COMPASS Pathways worked with frog to communicate their story and carve a new category for investors and patients alike.Brought to you by frog, a global creative consultancy. frog is part of Capgemini Invent. (https://www.frog.co)Find episode transcripts and relevant info (https://www.frog.co/designmind/design-mind-frogcast-ep-33-a-new-direction-for-mental-healthcare)Download the new frog report 'The Regenerative Compass' (https://go.frog.co/the-regenerative-compass)Learn more about the frog + COMPASS Pathways collaboration (https://www.frog.co/work/forging-a-new-path-for-mental-health)Visit COMPASS Pathways (https://compasspathways.com)Host/Writer: Elizabeth Wood, Editorial Director, frogResearch & Story Support: Camilla Brown, Senior Copyeditor, frogAudio Production: Richard Canham, Lizard Media (https://www.lizardmedia.co.uk)

Mikey and Roxy learn that the kids are NOT alright as they review the 1984 adaptation of Stephen King's Children of the Corn. ----- Children of the Corn (1984) https://www.imdb.com/title/tt0087050/ Stream for free on Tubi https://tubitv.com/movies/478814/children-of-the-corn?start=true ----- Referenced This Episode Victorian Death Photos aka Post-mortem photography https://en.wikipedia.org/wiki/Post-mortem_photography Stray (2022 video game) https://stray.game/ Never Been Kissed (1999) https://www.imdb.com/title/tt0151738/ Satanic Panic https://en.wikipedia.org/wiki/Satanic_panic John Wolfe on YouTube https://www.youtube.com/c/HarshlyCritical The Sopranos (TV series, 1999-2007) https://www.imdb.com/title/tt0141842/ ----- “George Goldsmith” played by Nick Costanza, on Instagram at https://www.instagram.com/nickcostanza/ and find him on the Reactivaders podcast at https://www.instagram.com/reactivaders/ Hosts: Mikey McCollor on Twitch at http://twitch.tv/mikeymccollor and Twitter at http://twitter.com/mikeymccollor Roxy Polk on Twitch at http://twitch.tv/roxypolk and Twitter at http://twitter.com/roxypolk Post-production and editing by Darryl Mott

In this special episode of “Everyone has a story: talking about mental health”, COMPASS Pathways' Co-founders, Ekaterina Malievskaia and George Goldsmith, chat to Kabir Nath, newly appointed Chief Executive Officer from 1 August 2022, and former Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co., Ltd. Kabir talks about his story, his new role, and making COMPASS's mission a reality.

George Goldsmith, Chairman, CEO and Cofounder of COMPASS Pathways, leaders in using psychedelics, magic mushrooms and LSD related compounds to treat depression and anxiety

Psychedelic therapy could provide a major breakthrough in the treatment of mental health disorders like depression, and now it's caught the attention of start-ups and venture capitalists. Laurence Knight hears from one man whose life was transformed by a single dose of the drug psilocybin - the psychoactive ingredient in magic mushrooms - after he volunteered for a research project exploring whether it could cure depression. He also visits the research team at King's College Hospital in London, who have just wrapped up the latest trials of the drug. The trials are being sponsored by the healthcare start-up Compass Pathways, and its founder and chief executive George Goldsmith explains why he hopes to use them to bring this therapy to the general public. Plus Amanda Eilean of venture capitalists Able Partners describes how quickly attitudes in the investor community are changing. (Picture credit: Getty Images)

A young couple find themselves lost on the backroads of Nebraska, eventually winding up in a seemingly deserted town of Gatlin. But the town is far from empty. As the couple soon discover, it is inhabited by a twisted cult of murderous children, thirsty for another blood sacrifice. Children of the Corn stars Linda Hamilton, Peter Horton, John Franklin, Courtney Gains, Robby Kiger, Anne Marie McEvoy, R.G. Armstrong, Julie Maddalena, Jonas Marlowe, John Philbin, and more. Cinematography by Joao Fernandes. Music by Jonathan Elias Angeles. Screenplay by George Goldsmith. Directed by Fritz Kiersch. Based on the 1977 short story by Stephen King.

Ekaterina Malievskaia MD, is Co-founder and Chief Innovation Officer of COMPASS Pathways (NASDAQ:CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Ekaterina received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia, and then moved to the US where she completed her Internal Medicine residency training. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area. She was a Clinical Instructor of Medicine at Mount Sinai School of Medicine, as well as a Research Professor at the City University of New York. After moving to London in 2011, Ekaterina worked in global health and medical philanthropy, focusing on improving outcomes in maternal and child health. She founded COMPASS Pathways with her husband George Goldsmith in 2016, having experienced at first hand the challenges in accessing evidence-based and effective mental health care for a family member. FIND EKATERINA ON SOCIAL MEDIA LinkedIn ================================ SUPPORT & CONNECT: Support on Patreon: https://www.patreon.com/denofrich Twitter: https://twitter.com/denofrich Facebook: https://www.facebook.com/denofrich YouTube: https://www.youtube.com/denofrich Instagram: https://www.instagram.com/den_of_rich/ Hashtag: #denofrich © Copyright 2022 Den of Rich. All rights reserved.

Ekaterina Malievskaia MD, is Co-founder and Chief Innovation Officer of COMPASS Pathways (NASDAQ:CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Ekaterina received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia, and then moved to the US where she completed her Internal Medicine residency training. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area. She was a Clinical Instructor of Medicine at Mount Sinai School of Medicine, as well as a Research Professor at City University of New York.After moving to London in 2011, Ekaterina worked in global health and medical philanthropy, focusing on improving outcomes in maternal and child health. She founded COMPASS Pathways with her husband George Goldsmith in 2016, having experienced at first hand the challenges in accessing evidence-based and effective mental health care for a family member.FIND EKATERINA ON SOCIAL MEDIALinkedIn================================PODCAST INFO:Podcast website: https://www.uhnwidata.com/podcastApple podcast: https://apple.co/3kqOA7QSpotify: https://spoti.fi/2UOtE1AGoogle podcast: https://bit.ly/3jmA7ulSUPPORT & CONNECT:Support on Patreon: https://www.patreon.com/denofrichTwitter: https://www.instagram.com/denofrich/Instagram: https://www.instagram.com/denofrich/Facebook: https://www.facebook.com/denofrich

The Survive Squad is known for their "corny" jokes, but will Stephen King's "Children of the Corn" (1984) prove to be too difficult of a maze to conquer? Join your hosts Malcolm and Brandon as they review and analyze Children of the Corn (1984), directed by Fritz Kiersch and written by Stephen King and George Goldsmith. Think you could survive? *NO COPYRIGHT INFRINGMENT IS INTENDED* Source Materials: Children of the Corn (1984) - IMDb Likert Scale Definition, Examples and Analysis | Simply Psychology Follow us on Social Media: Survive: The Podcast | Facebook Survive! The Podcast (@thesurvivepodcast) • Instagram photos and videos Survive! The Podcast (@survive_podcast) / Twitter Consider supporting the podcast: Survive! The Podcast is creating Podcasts | Patreon And check out these other great podcasts!: Robots Radio Podcast Network Shows | Robots Radio Podcast Network Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 11: The Unlikely Entrepreneur - Ekaterina Malievskaia When a mother's love knows no bounds. In this episode of Make or Break, we're joined by Dr. Ekaterina Malievskaia, co-founder and chief innovation officer of COMPASS Pathways, a life science company that develops psilocybin to help people with treatment resistant depression. Malievskaia and her husband, George Goldsmith, first started researching psilocybin - a chemical compound found in magic mushrooms - after an ongoing battle to find adequate help for their son who suffers from severe depression. The couple founded the charity COMPASS Pathways with the hope to get psilocybin approved and the drug to market. However they soon faced an obstacle; they would need to raise an eye-watering sum of $300 million, a task that for any charity would be close to impossible. This Podcast is brought to you by Radio Wolfgang for Auddy It was presented by Owen Bennett Jones and it featured Ekaterina Malievskaia It was produced by John Jo Devlin and Eli Block and the Executive Producer was Ellie DiMartino With support from The Open University - www.openuniversity.co.uk/management Learn more about your ad choices. Visit megaphone.fm/adchoices

George Goldsmith, Chairman, CEO, and Co-Founder of Compass Pathways, joins Michael Smerconish to talk leveraging synthetic psilocybin - yes, the stuff in shrooms - to treat mental illness.

In this episode we speak about the huge increase in mental health difficulties since the COVID-19 pandemic and the importance of opening up conversations to raise awareness and improve care. George Goldsmith, CEO and Co-founder of COMPASS is joined by Sir Norman Lamb, Chair of South London and Maudsley NHS Foundation Trust, Chairman of the Children's and Young People's Mental Health Coalition, a mental health campaigner, a Member of UK Parliament (MP) for 18 years, and a former UK government health minister.

George Goldsmith, Chairman, CEO and Co-founder of COMPASS Pathways introduces our new podcast series. We are facing a global mental health care crisis and the COVID-19 pandemic has only exacerbated this. Mental health care today works for some people but is not good enough for far too many. And yet there is still a stigma around talking about mental health. But when it comes to mental health, everyone has a story - whether that's about themselves, a family member, a friend or colleague. In this podcast series, we're going to speak to people about their mental health stories. We want to talk about the issues in mental health care and explore how we can improve the patient experience and ease suffering. Our first guests include Sir Norman Lamb – mental health campaigner and Chair of South London and Maudsley NHS Foundation Trust in the UK, and Jewel - singer-songwriter and mental health advocate. We hope to inspire, inform and provoke discussion, as our guests share their stories and ideas. Please do follow us on your favourite podcast app to ensure you don't miss episode one.

Today's episode features three experts, Josh Hardman, Michael Haichin, and Graham Pechenik as they analyze atai's S-1 in advance of their IPO. In this episode, we discuss:How atai went from idea to IPO in 3 yearsAn overview of atai's drug development programs and enabling technologiesThe platform's strategy and risksLinks to topics in this episode:Atai life sciencesEtifoxineEsketamine & arketamineAtai's S-1Psychedelic Pharmacist AssociationCalyx LawPsilocybin Alpha, Noetic Fundkratom, Salvinorin A, BNC210, mitragynineMike Novogratz, Christian Angermayer, George Goldsmith, Ekaterina Malievskaia, Peter ThielPureTech Health, Akili Interactive LabsBT's DemeRx EpisodeViridia Life Sciences, EmpathBio, Kures, Recognify Life SciencesRead the transcript here.Watch episode 9 on YouTube.Created by Greg Kubin and Matias SerebrinskyHost: Matias SerebrinskyProduced by Jonathan Davis & Zack FrankMarketing by DaisyMae VanValkenburghFind us at businesstrip.fmFollow us on Instagram and Twitter!Theme music by Dorian LoveAdditional music: The Innovation by Zack Frank (our very own sound engineer

Aadil Zaman, Partner at Wall Street Alliance Group discusses inflationary pressure on wages, and the pending U.S. infrastructure package. Dr. David Giljohann, CEO of Exicure discusses a new class of therapeutics used to treat diseases and the power of new technologies to develop treatments faster and cheaper. Kristina Hooper, Chief Global Market Strategist at Invesco, discusses the health of the U.S. economy, soaring housing prices, and wage growth. George Goldsmith, CEO of Compass Pathways discusses the mental health landscape and the integration of clinically driven psychedelic therapies.

In this week's Solidarity Fridays episode, Kyle, Joe, and Michelle first discuss an article from Salon.com that illustrates the flaws behind psychedelics being continually hailed as a miracle cure: has everyone just replaced the oft-criticized model of selling a “miracle” pill with selling the narrative that a few psychedelic sessions can cure anything? And inspired by Lenny Gibson, they point out that this rabid focus on medicalization is a direct result of these substances being made illegal in the first place. What would things look like if that had never happened? They then cover the developing drama between Compass Pathways and seemingly anyone compassionate and not making money from Compass Pathways' seedy behavior, represented this week by Tim Ferriss and David Bronner. The latest update includes Compass co-founder Christian Angermayer calling Ferriss' millions in donations a "drop in the ocean" in an odd donations-measuring contest, an email sent to investors saying competitors will never be able to bring a product to market due to the (absurd) patents they've filed (which Angermayer actually defended), and co-founder and CEO George Goldsmith mobilizing opposition to Oregon's Measure 109. This, not surprisingly, leads to a discussion about the competition between corporations, the race for patents, the drug war, how companies overestimate costs of drug-research and potential loss, how so little of the money being made is going to the Indigenous cultures we got all of this knowledge from, and more fun stuff in the endless mire of bullshit we have to wade through as a result of the drug war and greed. Notable Quotes “The only reason why we need to get this medicalized is because we made it illegal and we put it on a scheduling system. So, to make it official and legit and to deschedule it to make it into a medicine, we have to go through FDA-approval. ...What if it was never made illegal to begin with?” -Kyle (inspired by Lenny Gibson) “I really don’t believe in the antibiotic of psychiatry. You really have to actively work on changing the way you think and behave and react and all these things, and it’s a lot of hard work. Mushrooms make it more fun, but it’s a lot of hard work.” -Michelle “We’re not trying to be the enemy, but please be open to critique and understand where we’re coming from. In the same way a white male in America needs to understand American history and Imperialism and the crazy shit we’ve done, medicine should also try to own that a little bit. Like, why don’t certain communities trust you? Why don’t you get the results that the data says you should?” -Joe“This is not just about decrim. This is about restoring our rights as citizens of the world, regaining autonomy over our bodies, [and] improving science.” -Joe Links Salon.com: Why mental health researchers are studying psychedelics all wrong Psychedelicstoday.com: Dimitri Mugianis- Iboga, Psychedelic gas-lighting, and Structural Criticism Drugged: The Science and Culture Behind Psychotropic Drugs, by Richard J. Miller Saving Normal: An Insider's Revolt against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life, by Allen Frances Vice.com: The Race to Patent Psychedelics Is Just Getting Started Drbronner.com: Sounding the Alarm on Compass’s Interference with Oregon’s Psilocybin Therapy Program Zero to One: Notes on Startups, or How to Build the Future, by Peter Thiel Tim Ferriss: Some Thoughts on For-Profit Psychedelic Startups and Companies Tim Ferriss’ tweet/Christian Angermayer’s reply Vice.com: Investors Are Debating Who Should Own the Future of Psychedelics Pubs.acs.org: Ethical Concerns about Psilocybin Intellectual Property Ohchr.org: Article 31 of the United Nations Declaration on the Rights of Indigenous Peoples and the World Indigenous Nations (WIN) Games Narrative Medicine: The Use of History and Story in the Healing Process, by Lewis Mehl-Madrona Psychedelicstoday.com: Psychedelic Capitalism and Other Myths: Is the Joke On Us? Support the show! Patreon Leave us a review on Facebook or iTunes Share us with your friends Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics  

The Brides are back for season 2! This week, we get lost in Gatlin, Nebraska, and try to make even a little bit of sense out of the 1984 adaptation of Stephen King's Children of the Corn. Over the course of a purely chaotic hour we wonder who put Linda Hamilton in those unforgivable khakis, pick at the plot strands that go absolutely nowhere, and marvel at the clearly 35 year old 'stunt chest' in the church scene. Also, did you know that this film was supposed to be a metaphor for the Iranian revolution? Because we definitely didn't! Let's be honest - this movie is trash, but man, did we have fun trashing it. Here's to season 2, and better movies to come! Children of the Corn. 1984. Directed by Fritz Kiersch. Written by George Goldsmith. Starring Peter Horton, Linda Hamilton, John Franklin, and Courtney Gains

George Goldsmith is the co-founder and Executive Chairman of COMPASS Pathways, which aims to treat depression through psychedelic mushrooms.  In this conversation, we discuss mental health, depression, psychedelics, psilocybin therapy, and regulation. ======================= BlockFi provides financial products for crypto investors. Products include high-yield interest accounts, USD loans, and no fee trading. To start earning today visit: http://www.blockfi.com/Pomp ======================= Choice is a new self-directed IRA product that I'm really excited about. If you are listening to this, you are likely part of the 7.1 million bitcoin owners who have retirement accounts with dollars in them, but not bitcoin. I was in that situation too. Now you can actually buy real Bitcoin in your retirement account. I'm talking about owning your private keys and using tax-advantaged dollars to do it too. Absolute game changer. https://www.retirewithchoice.com/pomp ======================= Want to sell your wonderful internet business? Tiny partners with founders to give them quick, straightforward exits that protect their team and culture. We’ll make an offer within a week, close the deal within a month, and keep your business operating for the long term. Get in touch at tinycapital.com, and we’ll let you know within a couple of days. https://www.tinycapital.com/

The Sunday Times’ tech correspondent Danny Fortson brings on George Goldsmith to talk about how he started looking into psilocybin (3:45), its history of research (7:00), what he and his wife did before starting Compass (10:15), the 100 million people suffering treatment-resistant depression (14:15), launching the company (17:15), finding investors (18:45), being worth $800 million (23:00), what therapy looks like (26:20), patenting a natural substance (32:00), the legalisation movement (42:00), shooting for 2025 (44:30), his worst day of work (47:30), and building a business around an illegal drug (51:50). Support this show http://supporter.acast.com/dannyinthevalley. See acast.com/privacy for privacy and opt-out information.

George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks. Producer: Doni Holloway.

George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks. Producer: Doni Holloway. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Hear how George Goldsmith and Ekaterina Malievskaia from COMPASS Pathways are working to bring innovation psychedelic drug applications for depression. Learn what what this means for patients, regulators and trials. Panel Conversation Featuring: - George Goldsmith Co-Founder and Executive Chairman of COMPASS Pathways - Dr Ekaterina Malievskaia, Research and Development at COMPASS - Jane Metcalf, Founder of Neo.Life - Dr Amir Kalali, Chief Curator of CNS Summit This was recorded on the main stage at the 2019 CNS Summit which was held in Boca Raton, Florida. To learn more about CNS Summit and read full bios on each speaker, head to CNSSummit.org. Follow us on Twitter (@cnssummit). Hear and subscribe to all the episodes in this series on Health Podcast Network.

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Ekaterina Malievskaia MD, Chief Innovation Officer, Co-founder, and Research and Development Director, at COMPASS Pathways. Ira Pastor Comments: On a few past episodes, we have journeyed into the area psychedelic therapies, which broadly refers to therapeutic practices involving psychedelic drugs. In psychedelic therapy, in contrast to conventional psychiatric medication taken by the patient regularly or as-needed, patients generally remain in an extended psychotherapy session during the acute psychedelic activity with additional sessions both before and after in order to help integrate experiences with the drug. Psilocybin is a naturally occurring psychedelic pro-drug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms, which has mind-altering effects similar, in some aspects, to those of LSD, mescaline, and DMT, and include euphoria, visual and mental changes in perception, and spiritual experiences. Dr. Ekaterina Malievskaia: Dr. Ekaterina Malievskaia MD, is Chief Innovation Officer, Co-founder, and Research and Development Director, at COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, currently researching how psilocybin therapy could help people with disorders such as treatment-resistant depression, as well as other areas or improving mental well-being. Dr. Malievskaia received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia. After her Internal Medicine residency training, she completed an Environmental Medicine Fellowship at Mount Sinai School of Medicine and received her MSc in Public Health from New York University Medical School. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area. She was a Clinical Instructor of Medicine at Mount Sinai School of Medicine, as well as a Research Professor at City University of New York. After moving to London in 2011, Dr. Malievskaia worked in global health and medical philanthropy, focusing on improving outcomes in maternal and child health. She founded COMPASS Pathways with her husband George Goldsmith in 2016, having experienced at first hand the challenges in accessing evidence-based and effective mental health care for a family member. On this ideaXme episode we will hear from Dr. Malievskaia about: Her background; how she became interested in medicine, public health, and how she has arrived at the epicenter of psychedelic therapeutics and clinical medicine. A discussion about the ethnomedicinal (magic mushrooms) and early the 20th century pharmacological development history of Psilocybin. A discussion of the indication of treatment-resistant depression. A discussion of their Phase I trial evaluating the safety of COMP360 (psilocybin) for the treatment of patients with depression at King’s College London. Credits: Ira Pastor interview video, text, and audio. Follow Ira Pastor on Twitter:@IraSamuelPastor If you liked this interview, be sure to check out our interview on psychedelic drugs! Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio ,I Heart Radio, Google Podcasts, Spotify and more. ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

This week on Exponential, Amanda Lang asks George Goldsmith, Executive Chairman/CEO of Compass (Navigating Mental Health Pathways) why he decided to take this path towards helping the mental health community through innovation

"The most creative thing in the world for me is just how does an idea get transformed by the people who collect around it." - George Goldsmith, Co-Founder and CEO of Compass Pathways

Today we’re diving into the topic of Mental Health. It’s a topic we’ve covered before on this program, like in episode 63 with Dale Beerman of Think Pacifica, and Dr. Arshya Vahabzadeh from Brain Power back on episode 21.  In those episodes, we explored the use of mobile apps and wearables, and we looked at some problems that are being solved using these technologies.  Wouldn’t it be great if there were tools available that helped measure and quantify our mental health based on our physical activities and behaviors? Well, that’s why I wanted to introduce you to our next guest.  His company is pioneering work in measurement science to provide continuous, objective measures of cognition and mood that can potentially alert patients and providers to early signs of mental health deterioration. My guest is Dr. Thomas R. Insel, the Co-Founder & President of Mindstrong Health based in California.  Tom’s here to tell us about the research and work they’re doing to use information from cell phones to drive better, earlier and deeper understandings about mental health.    Tom is a psychiatrist and neuroscientist, and previously he was a Director of the National Institute of Mental Health, a Professor of Psychiatry at Emory University, and a leader of Verily’s Mental Health Team I was introduced to Tom my Marco Mohwinckel and George Goldsmith over at Compass Pathways, a UK-based company working to develop treatments to empower patients suffering with mental illness.  They are doing that by combining neuroscience, psychotherapy, psychopharmacology, and digital platforms.  You can find out more about their work by visiting compasspathways.com Thanks Marco and George for the introduction to Tom! You can get the show notes and links to the sites we mention in this episode by visiting Digital Health Today.com /82 Get the full show notes here. --- This episode of Digital Health Today is made possible thanks to our sponsors. Thank you! --- Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you ready for Stephen King month?! Matt and Steve are taking a trip to Nebraska to visit our new friend Isaac and review Children of the Corn (1984). Children of the Corn is rated R and was released into US theaters on March 9, 1984, on a budget of $800,000 (estimated). Director: Dritz KierschWriters: Stephen King (short story), George Goldsmith (screenplay) Children of the Corn Cast: Peter Horton as BurtLinda Hamilton as VickyR.G. Armstrong as DiehlJohn Franklin as IsaacCourtney Gains as MalachaiJohn Philbin as AmosJulie Maddalena as Rachel Children of the Corn Movies: Children of the Corn (1984)Children of the Corn II: The Final Sacrifice (1992)Children of the Corn III: Urban Harvest (1995)Children of the Corn IV: The GatheringChildren of the Corn V: Fields of Terror (1998)Children of the Corn 666: Isaac's Return (1999)Children of the Corn: Revelation (2001)Children of the Corn (2001)Children of the Corn: Genesis (2011)Children of the Corn: Runaway (2018) Children of the Corn BookChildren of the Corn is a short story by Stephen King, first published in the March 1977 issue of Penthouse, and later collected in King's 1978 collection Night Shift. The story involves a couple's exploration of a strange town and their encounters with its denizens after their vacation is sidelined by a car accident. Several films have been adapted from the short story and it spawned a horror franchise beginning in 1984. Buy the Arrow Special Edition of Children of the Corn Buy this amazing poster by Arrow Films Buy the Children of the Corn 6-Film Collection The Predator (2018) Movie ReviewMatt and Steve also take some time to review The Predator (2018). Will they survive being hunted down by the angry fans? Director: Shane BlackWriters: Fred Dekker and Shane Black (screenplay) Jim Thomas and John Thomas (based on characters created by) The Predator (2018) CastBoyd Holbrook as Quinn McKennaTrevante Rhodes as Nebraska WilliamsJacob Tremblay as Rory McKennaDeegan-Michael Key as CoyleOlivia Munn as Casey BracketSterling K. Brown as TraegerAlfie Allen as LynchAugusto Aguilera as Nettles How does Shane Black's sequel The Predator (2018) hold up to the original Predator (1987), Predator 2 (1990) and Predators (2010)? According to the critics, not well at all. Do Matt and Steve agree? Listen to find out their likes and dislikes. Discuss these movies and more on our Facebook page. You can also listen to us on iTunes, Podbean, Google Play, Spotify, Radio Public, Stitcher, and Youtube!      

The largest-ever clinical trial of a psychedelic drug will soon begin in Europe and North America. The drug is psilocybin - the active ingredient in magic mushrooms. The target is treatment-resistant depression.

Live from Psychedelic Science '17 in Oakland, this panel explores the future of psychiatry in the psychedelic context. In this conversational panel format, the conversation discucces with great candor and honesty all the pros, cons, triumphs and setbacks that have occurred within the last 10 years. Dr. Summergrad and Dr. Insel both share their experiences from the mental health and patient-doctor perspective.  Moderated by George Goldsmith and featuring Paul Summergrad, MD, and Thomas Insel, MD. George Goldsmith is a co-founder and director of COMPASS – a non-profit medical research organisation dedicated to accelerating access to evidence-led innovation in mental health and wellbeing. George’s early training and experience was a blend of cognitive psychology, clinical psychology and computer science. Paul Summergrad, M.D., is the Dr. Frances S. Arkin professor and chairman of the Department of Psychiatry and professor of medicine at Tufts University School of Medicine and psychiatrist-in-chief at Tufts Medical Center. Thomas Roland Insel is an American neuroscientist and psychiatrist who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia.

A young couple is trapped in a remote town where a dangerous religious cult of children believes that everyone over age 18 must be killed. DirectorFritz Kiersch WritersStephen King(based on the short story by) George Goldsmith(screenplay by) Stars Peter Horton Linda Hamilton R.G. Armstrong --- Send in a voice message: https://anchor.fm/gruesome-hertzogg/message Support this podcast: https://anchor.fm/gruesome-hertzogg/support